Market Insight - Chinese lawsuits point to emerging litigious culture
This article was originally published in Scrip
Executive Summary
In the face of robust pharmaceutical market growth, an increase in adverse drug reactions and higher consumer demands, is China's drugs industry facing a perfect storm, asks Eugene Chen.